US FDA finds 'significant violations' at Strides Pharma plant
Updated : July 17, 2019 11:05 AM IST
Shares of Strides fell 8.1 percent to Rs 347.10 per share in early trades on the National Stock Exchange. But soon the shares erased losses and traded only 1.9 percent down at Rs 370.55 per share at 10.19 AM.
The drugmaker was caught trying to dispose quality-control records, the FDA said in a letter made public on July 16.
The FDA's warning letter dated July 1, comes months after several Indian drugmakers including Sun Pharmaceutical Ltd and Dr.Reddy's Laboratories Ltd were named in a US lawsuit against Israeli drugmaker Teva Pharmaceutical Industries Ltd accusing it of conspiring to inflate drug prices and stifle competition for generic drugs.
Have you signed up for Primo, our daily newsletter?It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morningYOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more